Estrogen A-ring structure and antioxidative effect on lipoproteins

被引:71
作者
Badeau, M
Adlercreutz, H
Kaihovaara, P
Tikkanen, MJ
机构
[1] Univ Helsinki, Dept Med, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Div Clin Chem, FIN-00014 Helsinki, Finland
[3] Folkhalsan Res Ctr, Inst Prevent Med, FIN-00290 Helsinki, Finland
关键词
estrogen; antioxidant; lipoproteins; atherosclerosis;
D O I
10.1016/j.jsbmb.2005.04.034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The oxidative modification of lipoprotein particles is an important step in atherogenesis. Estrogens are known to be powerful antioxidants independently of their binding to the estrogen receptors and the hormonal functions. We explored the structural determinants for the antioxidant activity of a large number of estrogen derivatives (n = 43) in an aqueous lipoprotein solution in vitro by monitoring formation of conjugated dienes. Our results indicate that estrogen derivatives with an unsubstituted A-ring phenolic hydroxyl group with one or two adjacent methoxy groups provide strongest antioxidant protection of low density lipoprotein (LDL) and high density lipoprotein (HDL). The electron donating methoxy groups may enhance the antioxidant effect by weakening the phenolic O-H bond and providing stability to the formed phenoxyl radical. With some exceptions, compounds completely lacking unsubstituted hydroxyl groups in the A-ring exhibited no antioxidant effect, e.g. the most hydrophilic "tetrol" compound with three unsubstitured A-ring hydroxyl groups had no antioxidant effect. Moreover, additional hydroxyl groups in the B-, C- or D-ring seemed to weaken the antioxidant effect. Accordingly, both the presence of unsubstituted hydroxyl groups and adjacent substituents, as well as the lipophilicity of the derivatives determine the antioxidant activity of estrogen derivatives in aqueous lipoprotein solutions. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:271 / 278
页数:8
相关论文
共 35 条
[1]
Evidence for the role of high density lipoproteins in mediating the antioxidant effect of estrogens [J].
Abplanalp, W ;
Scheiber, MD ;
Moon, K ;
Kessel, B ;
Liu, JH ;
Subbiah, MTR .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 142 (01) :79-83
[2]
Mechanisms involved in the protective effect of estradiol-17β on lipid peroxidation and DNA damage [J].
Ayres, S ;
Abplanalp, W ;
Liu, JH ;
Subbiah, MTR .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 274 (06) :E1002-E1008
[3]
Neuroprotection against oxidative stress by estrogens: Structure-activity relationship [J].
Behl, C ;
Skutella, T ;
Lezoualch, F ;
Post, A ;
Widmann, M ;
Newton, CJ ;
Holsboer, F .
MOLECULAR PHARMACOLOGY, 1997, 51 (04) :535-541
[4]
Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's [J].
Bhavnani, BR .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 85 (2-5) :473-482
[5]
ASSESSMENT OF THE IMPORTANCE OF CHANGES IN GROUND-STATE ENERGIES ON THE BOND-DISSOCIATION ENTHALPIES OF THE O-H BONDS IN PHENOLS AND THE S-H BONDS IN THIOPHENOLS [J].
BORDWELL, FG ;
ZHANG, XM ;
SATISH, AV ;
CHENG, JP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (15) :6605-6610
[6]
Estradiol enhances the resistance of LDL to oxidation by stabilizing apoB-100 conformation [J].
Brunelli, R ;
Mei, G ;
Krasnowska, EK ;
Pierucci, F ;
Zichella, L ;
Ursini, F ;
Parasassi, T .
BIOCHEMISTRY, 2000, 39 (45) :13897-13903
[7]
One site on the apoB-100 specifically binds 17-β-estradiol and regulates the overall structure of LDL [J].
Brunelli, R ;
Greco, G ;
Barteri, M ;
Krasnowska, EK ;
Mei, G ;
Natella, F ;
Pala, A ;
Rotella, S ;
Ursini, F ;
Zichella, L ;
Parasassi, T .
FASEB JOURNAL, 2003, 17 (12) :2127-+
[8]
Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus [J].
Brussaard, HE ;
Leuven, JAG ;
Kluft, C ;
Krans, HMJ ;
vanDuyvenvoorde, W ;
Buytenhek, R ;
vanderLaarse, A ;
Princen, HMG .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (02) :324-330
[9]
CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75